Literature DB >> 21810661

Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes.

Matthew Taylor1, Sharon Graw, Gianfranco Sinagra, Carl Barnes, Dobromir Slavov, Francesca Brun, Bruno Pinamonti, Ernesto E Salcedo, William Sauer, Stylianos Pyxaras, Brian Anderson, Bernd Simon, Julius Bogomolovas, Siegfried Labeit, Henk Granzier, Luisa Mestroni.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited genetic myocardial disease characterized by fibrofatty replacement of the myocardium and a predisposition to cardiac arrhythmias and sudden death. We evaluated the cardiomyopathy gene titin (TTN) as a candidate ARVC gene because of its proximity to an ARVC locus at position 2q32 and the connection of the titin protein to the transitional junction at intercalated disks. METHODS AND
RESULTS: All 312 titin exons known to be expressed in human cardiac titin and the complete 3' untranslated region were sequenced in 38 ARVC families. Eight unique TTN variants were detected in 7 families, including a prominent Thr2896Ile mutation that showed complete segregation with the ARVC phenotype in 1 large family. The Thr2896IIe mutation maps within a highly conserved immunoglobulin-like fold (Ig10 domain) located in the spring region of titin. Native gel electrophoresis, nuclear magnetic resonance, intrinsic fluorescence, and proteolysis assays of wild-type and mutant Ig10 domains revealed that the Thr2896IIe exchange reduces the structural stability and increases the propensity for degradation of the Ig10 domain. The phenotype of TTN variant carriers was characterized by a history of sudden death (5 of 7 families), progressive myocardial dysfunction causing death or heart transplantation (8 of 14 cases), frequent conduction disease (11 of 14), and incomplete penetrance (86%).
CONCLUSIONS: Our data provide evidence that titin mutations can cause ARVC, a finding that further expands the origin of the disease beyond desmosomal proteins. Structural impairment of the titin spring is a likely cause of ARVC and constitutes a novel mechanism underlying myocardial remodeling and sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810661      PMCID: PMC3167235          DOI: 10.1161/CIRCULATIONAHA.110.005405

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity.

Authors:  A Freiburg; K Trombitas; W Hell; O Cazorla; F Fougerousse; T Centner; B Kolmerer; C Witt; J S Beckmann; C C Gregorio; H Granzier; S Labeit
Journal:  Circ Res       Date:  2000-06-09       Impact factor: 17.367

2.  Accounting for human polymorphisms predicted to affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

3.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).

Authors:  N Tiso; D A Stephan; A Nava; A Bagattin; J M Devaney; F Stanchi; G Larderet; B Brahmbhatt; K Brown; B Bauce; M Muriago; C Basso; G Thiene; G A Danieli; A Rampazzo
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

4.  The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.

Authors:  M L Bang; T Centner; F Fornoff; A J Geach; M Gotthardt; M McNabb; C C Witt; D Labeit; C C Gregorio; H Granzier; S Labeit
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

5.  Titin mutations as the molecular basis for dilated cardiomyopathy.

Authors:  Manatsu Itoh-Satoh; Takeharu Hayashi; Hirofumi Nishi; Yoshinori Koga; Takuro Arimura; Takeshi Koyanagi; Megumi Takahashi; Shigeru Hohda; Kazuo Ueda; Tatsuhito Nouchi; Michiaki Hiroe; Fumiaki Marumo; Tsutomu Imaizumi; Michio Yasunami; Akinori Kimura
Journal:  Biochem Biophys Res Commun       Date:  2002-02-22       Impact factor: 3.575

6.  Cardiac titin isoforms are coexpressed in the half-sarcomere and extend independently.

Authors:  K Trombitás; Y Wu; D Labeit; S Labeit; H Granzier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

7.  Molecular mechanics of cardiac titin's PEVK and N2B spring elements.

Authors:  Kaori Watanabe; Preetha Nair; Dietmar Labeit; Miklós S Z Kellermayer; Marion Greaser; Siegfried Labeit; Henk Granzier
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

8.  Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.

Authors:  Brenda Gerull; Michael Gramlich; John Atherton; Mark McNabb; Karoly Trombitás; Sabine Sasse-Klaassen; J G Seidman; Christine Seidman; Henk Granzier; Siegfried Labeit; Michael Frenneaux; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2002-01-14       Impact factor: 38.330

9.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

10.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

View more
  103 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

2.  Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Ting-Ting Hong; Rebecca Cogswell; Cynthia A James; Guson Kang; Clive R Pullinger; Mary J Malloy; John P Kane; Julianne Wojciak; Hugh Calkins; Melvin M Scheinman; Zian H Tseng; Peter Ganz; Teresa De Marco; Daniel P Judge; Robin M Shaw
Journal:  Heart Rhythm       Date:  2012-01-31       Impact factor: 6.343

3.  Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Francesca Brun; Carl V Barnes; Gianfranco Sinagra; Dobromir Slavov; Giulia Barbati; Xiao Zhu; Sharon L Graw; Anita Spezzacatene; Bruno Pinamonti; Marco Merlo; Ernesto E Salcedo; William H Sauer; Matthew R G Taylor; Luisa Mestroni
Journal:  J Med Genet       Date:  2014-08-25       Impact factor: 6.318

4.  King of hearts: a splicing factor rules cardiac proteins.

Authors:  Wolfgang A Linke; Sandra Bücker
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 5.  Titin is a major human disease gene.

Authors:  Martin M LeWinter; Henk L Granzier
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

Review 6.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 7.  Molecular mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy.

Authors:  Jeffrey E Saffitz
Journal:  Cardiovasc Pathol       Date:  2017-02-27       Impact factor: 2.185

Review 8.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature.

Authors:  Brittney Murray
Journal:  J Genet Couns       Date:  2012-03-17       Impact factor: 2.537

Review 9.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

10.  Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.

Authors:  Kai Chen; Jiangping Song; Zhen Wang; Man Rao; Liang Chen; Shengshou Hu
Journal:  Clin Cardiol       Date:  2018-05-11       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.